The Celebrate Soulfully event honoring Black culture will run throughout February at Disneyland, Downtown Disney and the Disney hotels.

Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...

Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday.Invest with Confidence: ...

California’s peak stomach flu season is expected to continue to April. Hand sanitizers don't kill the illness, which spreads ...

BlockFills, a digital assets technology and trading firm for institutions and professional traders, has announced a ...

12. “Don’t Believe Everything You Think (expanded ed.)” by Joseph Nguyen (Authors Equity) ...

A phase 3 trial evaluating sotatercept-csrk (Winrevair™) in adults with pulmonary arterial hypertension (PAH; World Health Organization Group 1) ...

The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.

Merck said the Phase 3 "Hyperion" study, which was evaluating Winrevair versus placebo in recently diagnosed adults with PAH at intermediate or high risk of disease progression, had lost clinical ...

The CoinDesk 20 Index provides a benchmark for institutional investors beyond Bitcoin and Ethereum exchange-traded funds. It has gained adoption among hedge funds and asset managers since its ...

(RTTNews) - Merck & Co Inc. (MRK), Thursday said it has decided to stop the Phase 3 HYPERION study evaluating Winrevair in pulmonary arterial hypertension (PAH). The HYPERION study is designed to ...

Institution-focused digital asset technology and trading firm BlockFills is collaborating with CoinDesk Indices to launch ...